Recap: EyePoint Pharmaceuticals Q4 Earnings


EyePoint Pharmaceuticals EYPT reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


EyePoint Pharmaceuticals missed estimated earnings by 11.32%, reporting an EPS of $-0.59 versus an estimate of $-0.53.

Revenue was up $4.41 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.18 which was followed by a 7.4% increase in the share price the next day.

Here's a look at EyePoint Pharmaceuticals's past performance:


Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.40 -0.43 -0.46 -0.17
EPS Actual -0.58 -0.42 -0.50 -1
Revenue Estimate 9.84M 9.13M 7.93M 20.44M
Revenue Actual 9.06M 9.01M 7.32M 7.13M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarningsNews